non-relapse mortality
Showing 1 - 25 of >10,000
Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and
Completed
- Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
-
Roma, ItalyServizio E Dh Di Ematologia
Feb 23, 2023
Identify Resected Non-small-cell Lung Cancer With High Risk of
Recruiting
- Non-small Cell Lung Cancer Stage IIIA
- Resected non small cell lung cancer
-
Toulouse, FranceJulien MAZIERES
Feb 8, 2023
Mortality of US Fibrodysplasia Ossificans Progressiva (FOP)
Active, not recruiting
- Fibrodysplasia Ossificans Progressiva (FOP)
- Non-Interventional
-
Tarrytown, New YorkRegeneron
Sep 26, 2023
Cardiogenic Acute Pulmonary Edema in Subjects Over 75 Years Old:
Recruiting
- Cardiogenic Pulmonary Edema
-
Strasbourg, FranceGériatrie - Service de Soins de Soins Médicaux et de Réadaptatio
Oct 24, 2023
Myocardial Injury After Non-cardiac Surgery, Abdomen, Acute Trial in Hillerød (Troponin I)
Completed
- Myocardial Injury After Non-cardiac Surgery
- Abdomen, Acute
- Troponin I
-
Hillerød, DenmarkCopenhagen University Hospital - North Zealand
Jul 2, 2023
Memory CD8+ T Cells With Sepsis Severity and
Recruiting
- Sepsis
- Inflammatory Response
-
Wuhan, Hubei, ChinaDepartment of Critical Care Medicine, Union Hospital, Tongji Med
May 16, 2023
Risperidone ISM® in Schizophrenia Patients Hospitalised Due
Not yet recruiting
- Schizophrenia
- Risperidone ISM
- (no location specified)
Jul 28, 2022
Geriatric Non-bedded Night in Emergency Department:Multicenter
Completed
- in Hospital Mortality
- Geriatric
-
Paris, FranceEmergency department Hospital Pitié-Salpêtrière
Apr 6, 2023
Surgery, Surgery--Complications Trial in Loveland (Morbidity and mortality conference toolkit)
Recruiting
- Surgery
- Surgery--Complications
- Morbidity and mortality conference toolkit
-
Loveland, ColoradoMedical Center of the Rockies
Apr 27, 2022
Relapse After Conversion Hepatectomy for Initially Unresectable
Completed
- Colorectal Cancer
- Liver Metastases
- Repeat Liver Surgery
- Non-Repeat Liver Surgery
- (no location specified)
Jul 16, 2022
Postoperative Complications in Major Non-cardiac Surgery:
Recruiting
- Goal Directed Therapy
- +3 more
-
Amiens, FranceCHU Amiens-Picardie
Apr 25, 2023
Hematologic Malignancy Trial in Chengdu (Allogeneic Hematopoietic Stem Cell Transplantation)
Recruiting
- Hematologic Malignancy
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Mar 12, 2022
Recurrent Cancer, Previous Radiation Trial (Radiation by protontherapy associated to nanoparticles injection)
Not yet recruiting
- Recurrent Cancer
- Previous Radiation
- Radiation by protontherapy associated to nanoparticles injection
- (no location specified)
Apr 19, 2022
Postoperative Morbidity / Mortality Rates of Pulmonary
Active, not recruiting
- oPAP Should be > 25mmHg in Right Heart Catheterization at Rest
- There Should be Patients Who Will Undergo Non-cardiac and Non-obstetric Surgery
- no intervention
-
Ankara, TurkeyBaskent University Ankara Hospital
Sep 30, 2022
All Conditions Requiring Non-cardiac Surgery Trial (Training)
Not yet recruiting
- All Conditions Requiring Non-cardiac Surgery
- Training
- (no location specified)
Oct 30, 2023
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Cell Therapy, NSCLC Trial in Fukuoka-shi, Kitakyushu, Kurume (Biological)
Recruiting
- Cell Therapy
- NSCLC
- Biological
-
Fukuoka-shi, Fukuoka, Japan
- +2 more
Jan 13, 2022
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:
Not yet recruiting
- B-cell Non Hodgkin Lymphoma
- +2 more
- (no location specified)
Jun 22, 2023
Atherogenic Index of COVID-19 and Upcoming Cardiac Morbidity and
Completed
- COVID-19
- Atherogenic Index of Plasma
-
Tanta, EgyptTanta university
Feb 4, 2022
Participants Receiving Nivolumab in Adjuvant Setting for
Active, not recruiting
- Melanoma
-
Lille, FranceLocal Institution
Mar 17, 2022
Impact of COVID-19 Outbreak on Non-COVID-19 Patients
Enrolling by invitation
- COVID-19
-
Geneva, Canton De Genève, SwitzerlandGeneva University Hospital
Mar 10, 2022